Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 6/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.32 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10899969 | 0.96 | ANPEP (0.53) | ANPEPTSHRLMNATHRBALDH1A1 | |
| SCHEMBL1237 | 0.96 | ANPEP (0.53) | ANPEPTSHRLMNATHRBALDH1A1 | |
| SCHEMBL952691 | 0.92 | ANPEP (0.50) | ANPEPTSHRLMNATHRBALDH1A1 | |
| SCHEMBL9814415 | 0.92 | ANPEP (0.50) | ANPEPTSHRLMNATHRBALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL28825800 | 0.92 | ANPEP (0.50) | ANPEPTSHRLMNATHRBALDH1A1 | |
| SCHEMBL3887127 | 0.92 | ANPEP (0.50) | ANPEPTSHRLMNATHRBALDH1A1 | |
| Lithium Ion SCHEMBL22426275 | 0.89 | ANPEP (0.47) | ANPEPTSHRLMNATHRBALDH1A1 | |
| SCHEMBL2495893 | 0.89 | TSHR (0.47) | ANPEPTSHRLMNATHRBALDH1A1 | |
| Potassium Ion SCHEMBL22426233 | 0.89 | ANPEP (0.47) | ANPEPTSHRLMNATHRBALDH1A1 | |
| SCHEMBL88650 | 0.85 | TSHR (0.50) | ANPEPTSHRLMNATHRBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119710788-A | Cobalt-ruthenium-based catalytic electrode capable of being electrochemically reconstructed in situ, preparation method thereof and application thereof in electrocatalytic nitrate reduction | 中国建筑第八工程局有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-116289205-B | Nano-dyeing method of antibacterial fabric for mask based on lignin | 广东省科学院微生物研究所(广东省微生物分析检测中心) | 2024-05-14 | — | — | CN | claimed |
| CN-116289205-A | Nano-dyeing method of antibacterial fabric for mask based on lignin | 广东省科学院微生物研究所(广东省微生物分析检测中心) | 2023-06-23 | — | — | CN | claimed |
| CN-110218160-B | Quinic acid derivative, and preparation method and application thereof | 暨南大学 | 2022-05-24 | — | — | CN | claimed |
| CN-110156628-B | Cyclotriol derivative and preparation method and application thereof | 暨南大学 | 2022-05-17 | — | — | CN | claimed |
| US-10014475-B2 | Graphene nanoribbons as semiconductors for organic thin film transistors | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2018-07-03 | — | — | US | claimed |
| US-20160087212-A1 | GRAPHENE NANORIBBONS AS SEMICONDUCTORS FOR ORGANIC THIN FILM TRANSISTORS | CRESTLINE DIRECT FINANCE, L.P. | 2016-03-24 | — | — | US | claimed |
| WO-2014171931-A1 | GRAPHENE NANORIBBONS AS SEMICONDUCTORS | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-10-23 | — | — | WO | claimed |
| EP-0284371-B1 | NOVEL OPTICALLY ACTIVE BENZENE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND LIQUID-CRYSTALLINE SUBSTANCES CONTAINING SAID DERIVATIVES AS ACTIVE INGREDIENT AND OPTICAL SWITCHING ELEMENTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1992-09-16 | — | — | EP | claimed |
| EP-0284371-A2 | Novel optically active benzene derivatives, process for producing the same and liquid-crystalline substances containing said derivatives as active ingredient and optical switching elements | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-09-28 | — | — | EP | claimed |
| US-4703127-A | Process for the preparation of prostanoids | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1987-10-27 | — | — | US | claimed |
| EP-0009892-B1 | CYCLOPENTENONE AND CYCLOPENTENOL DERIVATIVES AND PROCESSES FOR THEIR PREPARATION | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1983-04-13 | — | — | EP | claimed |
| EP-0009892-A1 | Cyclopentenone and cyclopentenol derivatives and processes for their preparation | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1980-04-16 | — | — | EP | claimed |
| US-20250250216-A1 | CYCLIC COMPOUND HAVING IODINE ATOM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-08-07 | — | — | US | disclosed |
| WO-2025106637-A1 | CINNOLINE DERIVATIVES USEFUL AS BAF MODULATORS | FOGHORN THERAPEUTICS INC. (US) | 2025-05-22 | — | — | WO | disclosed |
| CN-119710788-A | Cobalt-ruthenium-based catalytic electrode capable of being electrochemically reconstructed in situ, preparation method thereof and application thereof in electrocatalytic nitrate reduction | 中国建筑第八工程局有限公司 | 2025-03-28 | — | — | CN | disclosed |
| US-4243683-A | INSECTICIDES, MITICIDES | MAY & BAKER LIMITED (GB) | 1981-01-06 | — | — | US | disclosed |
| EP-0018594-A2 | Process for the preparation of 3-(1-hydroxyethyl)-azetidinones | MERCK & CO. INC. (US) | 1980-11-12 | — | — | EP | disclosed |
| EP-0009892-A1 | Cyclopentenone and cyclopentenol derivatives and processes for their preparation | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1980-04-16 | — | — | EP | disclosed |
| US-4082810-A | STEREOSELECTIVE HYDROGENATING AGENTS | ALDRICH-BORANES, INC. (US) | 1978-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10014475-B2 | Graphene nanoribbons as semiconductors for organic thin film transistors | STRA6, OR10J3, EPCAM | ANPEP 4396/4885TSHR 1452/4885LMNA 4404/4885 |
| US-20250250216-A1 | CYCLIC COMPOUND HAVING IODINE ATOM | IGF1R, SSTR1, CCNI | ANPEP 4602/4885TSHR 19/4885LMNA 3507/4885 |
| US-20160087212-A1 | GRAPHENE NANORIBBONS AS SEMICONDUCTORS FOR ORGANIC THIN FILM TRANSISTORS | STRA6, OR10J3, EPCAM | ANPEP 4396/4885TSHR 1452/4885LMNA 4404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.